ABSTRACT: Backgro und: Rapid action stopping leads to global motor suppression. This is shown by studies using transcranial magnetic stimulation to measure corticospinal excitability of task-unrelated effectors (e.g., from the hand during speech stopping). We hypothesize that this global suppression relates to the STN of the basal ganglia. Several STN local field potential studies in PD patients have shown increased ß-band power during successful stopping. Objectives: Here, we aimed to test whether this STN ß-band activity indexes global motor suppression measured by transcranial magnetic stimulation. Methods: We studied 9 medicated PD patients (age, 47-67 years; mean, 55.8; 3 female) who were implanted with STN-DBS electrodes. Participants performed a vocal stop-signal task (i.e., they had to occasionally stop a vocal response) while we simultaneously recorded local field potentials from right STN and delivered transcranial magnetic stimulation to primary motor cortex to measure corticospinal excitability from a taskunrelated hand muscle (first dorsal interosseous).
ABSTRACT: Backgro und: Rapid action stopping leads to global motor suppression. This is shown by studies using transcranial magnetic stimulation to measure corticospinal excitability of task-unrelated effectors (e.g., from the hand during speech stopping). We hypothesize that this global suppression relates to the STN of the basal ganglia. Several STN local field potential studies in PD patients have shown increased ß-band power during successful stopping. Objectives: Here, we aimed to test whether this STN ß-band activity indexes global motor suppression measured by transcranial magnetic stimulation. Methods: We studied 9 medicated PD patients (age, 47-67 years; mean, 55.8; 3 female) who were implanted with STN-DBS electrodes. Participants performed a vocal stop-signal task (i.e., they had to occasionally stop a vocal response) while we simultaneously recorded local field potentials from right STN and delivered transcranial magnetic stimulation to primary motor cortex to measure corticospinal excitability from a taskunrelated hand muscle (first dorsal interosseous).
Results: Replicating previous results, STN ß-band power was increased (P < 0.005) and corticospinal excitability was reduced (P 5 0.024; global motor suppression) during successful stopping. As hypothesized, global motor suppression was greater for successful stop trials with higher STN ß-power (median split: P 5 0.043), which was further evident in a negative correlation between single-trial STN ß-power and corticospinal excitability (mean, r 5 -0.176; P 5 0.011). C on c lus i o n: These findings link stopping-related global motor suppression to STN ß-band activity through simultaneous recordings of STN and corticospinal excitability. The results support models of basal ganglia function that propose the STN has broad motor suppressive effects. V C 2016 International Parkinson and Movement Disorder Society Key W ords: response inhibition; subthalamic nucleus; beta-band; motor evoked potentials; corticospinal excitability
Quickly stopping an initiated movement is a wellstudied control process. It is implemented by a frontobasal ganglia network including the presupplementary motor area, the right inferior frontal cortex, and the STN of the basal ganglia (for reviews, see previous works [1] [2] [3] [4] ). An interesting feature of rapid action stopping is its global motor effects, evident from studies that measure corticospinal excitability (CSE) using single-pulse transcranial magnetic stimulation (TMS) of the primary motor cortex. During rapid actionstopping, CSE is reduced not only in the targeted motor effector, but also in task-unrelated motor effectors, even at rest. For example, stopping the hand leads to CSE reductions in the leg, 5, 6 and stopping eye movements or speech leads to reduced CSE of the hand. 7, 8 The neural mechanism underlying stoppingrelated global motor suppression is currently unknown, but one possibility is that it relates to the STN. STN activity is increased during action stopping in single-unit recordings from rodents, monkeys, and humans, [9] [10] [11] , in functional MRI (fMRI), 12, 13 and in local field potential (LFP) recordings from Parkinson's disease (PD) patients with implanted STN electrodes (especially in the ß frequency band 11, [14] [15] [16] ; 12-24 Hz 17 ). Lesions to the STN in rodents 18 and humans 19 also adversely affect action stopping. Anatomical tracing studies suggest that the STN has a wide projection to the basal ganglia output nuclei, 20 leading to proposals that it could issue a broad, nonselective stop command. [21] [22] [23] Here, we tested whether global suppression of CSE (measured by TMS) relates to STN activity (measured by intracranial depth electrodes) during action stopping.
We studied 9 patients with implanted STN electrodes for the treatment of PD. They performed a vocal version of the stop-signal task (SST). We recorded LFPs from the STN, while simultaneously delivering TMS over the hand area of the primary cortex to measure global motor suppression. Based on the findings presented above, we expected that successful stopping would be accompanied by both increased STN beta-band activity 15 and reduced CSE from the task-unrelated hand. 7 Importantly, we predicted that greater single-trial STN beta-band activity during successful stopping would relate to greater CSE reduction: that is, greater betaband activity immediately before the CSE probe should correspond to greater global motor suppression.
Materials and Methods

Participants
Nine right-handed PD patients undergoing STN electrode (Medtronic model 3387; Medtronic, Dublin, Ireland) implantation for DBS (age, 47-67 years; mean, 55.8; 3 female) took part in the experiment. Patients were tested on their usual therapeutic medications to best normalize motor and cognitive abilities. Patients were tested 1 to 4 days postsurgery, when the leads remained externalized, before connection to the pulse generator. All patients provided written informed consent, and the protocol was approved by the University Health Network (Toronto) Research Ethics Board.
Paradigm
We used a vocal version of the SST (Fig. 1) . Each trial began with a fixation cross (1,000 ms), followed by a go stimulus (the letters T or K). Participants were instructed to respond as fast as possible by speaking the letter into a microphone (1,500-ms deadline) unless a stop signal appeared (the letter turned red). This happened pseudorandomly, with a probability of 33%. The delay between stop signal and go stimulus (stopsignal delay; SSD) was initially set to 200 ms and then automatically adjusted to achieve a probability of successful stopping [p(stop)] of 0.5 (SSD was increased by 50 ms after successful and decreased by 50 ms after failed stopping). Participants were instructed that successful stopping and quick responding were equally important. After response emission, the letter disappeared and the intertrial interval began (overall trial duration: 3,500 ms).
Materials
Stimuli were presented on an Apple MacBook (Apple, Cupertino, CA) running MATLAB (The MathWorks, Inc., Natick, MA) and Psychtoolbox 3.
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Responses were recorded using a Logitech USB microphone (Logitech, Romanel-sur-Morges, Switzerland).
Procedure
First, the microphone was manually calibrated to detect the voice onset of each participant (see Wessel 
TMS
TMS was performed with a 6 cm figure-of-eight coil, using two Magstim 200 stimulators and a Bistim module (Magstim Company, Dyfed, UK), delivering stimuli by alternating between stimulators. The area that elicited the best motor response in the right first dorsal interosseous (FDI) muscle was established over the left M1 with the coil held approximately 45 degrees to the midsagittal line (approximately perpendicular to the central sulcus). The direction of the induced current was from posterior to anterior and was optimal to activate the corticospinal neurons transynaptically. The optimal position was marked on the scalp to ensure identical placement of the coil throughout the experiment. A suprathreshold pulse (minimum stimulus intensity that produced >1 mV motor-evoked potentials [MEPs] in five of ten trials) was used throughout the experiment. TMS was applied at 110% of the threshold (mean intensity 5 56% of maximum output; minimum 5 44%; maximum 5 70%).
Based on our earlier article on global motor suppression during the vocal SST, 7 we time-locked TMS pulses to an online estimate of go-trial reaction time (GoRT). Specifically, GoRT was initially quantified based on the LFP-only phase, and then updated in the simultaneous LFP-TMS phase through a moving average of the previous 30 go trials. Stimulation was delivered at GoRT minus 100 ms, which corresponds to the time point of maximal motor suppression. 7 Based on this calculation, the stimulation occurred on average at 587 (go trials), 572 (successful stop trials), and 575 ms (failed stop trials) post-go stimulus (repeatedmeasures analysis of variance [rmANOVA] revealed no systematic differences between conditions; P > 0.16). On 30 random go trials, stimulation was applied in the intertrial interval (500 ms after the response deadline) instead of at GoRT minus 100 ms. These trials served as a baseline for normalization. On trials following these baseline trials, no stimulation was delivered to allow the stimulators to recharge.
LFP and EMG Recording
LFP was recorded from all four contacts of the bilateral STN depth electrodes using the externalized lead. We focused on the right STN because an fMRI study showed greater activity in the right STN during actionstopping, 12 which is confirmed by a meta-analytic search of "response inhibition" on neurosynth.org. However, we also present the results from the left electrodes. The signal was amplified using SynAmp amplifiers and digitized using a Neuroscan system (gain, 2,500; Neuroscan Laboratories, El Paso, TX). LFP signals were sampled at 2,500 Hz and band-pass filtered between 1 and 100 Hz. EMG was recorded by adhesive electrodes (9-mm-diameter Ag-AgCl electrodes; active electrode placed over the muscle belly, reference electrode over the metacarpophalangeal joint of the index finger) from the right FDI muscle and amplified (sampling rate: 2,500 Hz; bandpass filter: 30-500 Hz).
Behavioral Analysis
We quantified GoRT (voice onset on correct go trials), reaction time (RT) on failed stop trials (FsRT; voice onset on trials with stop signals), mean SSD, and stop-signal reaction time (SSRT). GoRT was compared to FsRT using a paired-samples t test to ensure that SSRT calculations using the mean method 26 were appropriate. SSRT was calculated by subtracting the average SSD from the average GoRT.
STN-LFP Beta Difference Validation
We analyzed the unimodal LFP data to ensure that the previously reported STN beta-power increase for successful versus failed stopping 15 was also present in our sample. Raw data from the LFP-only phase were imported into MATLAB (The MathWorks, Inc.), rereferenced to adjacent-neighbor dipolar references (contact 0 -contact 1, contact 1 -contact 2, and so forth), and resampled to 500 Hz. After visual inspection and artifact rejection, event-related spectral perturbation (ERSP) was quantified using the absolute of the Hilbert transformation for 13 individual frequencies spanning the beta band (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) ; frequency window: 6 0.5 Hz). The ERSP was quantified in units of percent change from baseline (-500 to 0 ms before the go signal) and averaged for successful and failed stop trials separately, over a period of 1,000 ms after the stop signal. Differences in beta-band power between the two trial types were tested using sample-to-sample Wilcoxon's signedrank tests at a two-sided P value of 0.05, which was corrected to P 5 0.004 to correct for the comparison of multiple frequencies (Bonferroni correction for 13 individual frequencies). The nonparametric Wilcoxon test was used because neural activity is likely non-normally distributed, and our sample size was limited to N 5 9.
Global CSE Suppression Validation
We analyzed the CSE data to ensure that the previously reported CSE reduction for the FDI muscle during vocal stopping 7 was also present in our patient sample. CSE was quantified from the MEP in the EMG trace. After import into MATLAB, EMG data were notch filtered at 60 Hz. MEP amplitudes were then quantified using a peak-to-peak measurement in
the period 50 ms after the TMS stimulus. The accuracy of the automated quantification was checked by visual inspection of each individual trial (trial type was blinded). Trials with visible artifacts and trials in which the automated algorithm failed were rejected from subsequent analysis, as were trials in which TMS occurred after response emission (this could happen because of the probabilistic nature of the GoRT forecast and trialby-trial variability in RT). MEPs were normalized by the average MEP on the 30 baseline trials to account for interindividual variability. MEPs were averaged separately for each trial type (go, successful stop, and failed stop) and compared using rmANOVA (two-sided P 5 0.05). Furthermore, we calculated planned contrasts of successful stop < go and successful stop < failed stop, (P 5 0.05, two-sided).
Simultaneous LFP-TMS Analysis
We tested our main hypothesis based on the simultaneous LFP-TMS data. For each stop trial with a valid MEP in the simultaneous LFP-TMS phase, beta-band power was quantified immediately before the TMS pulse. This period (168 to 0 ms before the TMS stimulus, which fits two cycles at the lower frequency bound of 12 Hz) was transformed into time-frequency space using a hamming-windowed fast Fourier transformation (FFT). Based on the mean TMS stimulation time on successful stop trials (572 ms post-go stimulus), this time period ranged from 404 to 572 ms after go-signal onset (which corresponds to 41-209 ms post-stop-signal onset). FFT estimates for the beta band were averaged, and the FFT average for a baseline period spanning 168 ms before go stimulus onset was subtracted. To select the bipolar STN channel for the LFP-MEP analysis (from all available dipolar montages), we quantified the beta-band difference between all stop and go trials for each dipolar channel. We then selected the channel with the biggest difference between these two trial types. This difference contrast served as a functional localizer based on past literature. 15 This does not bias the analysis toward finding a relation with the MEP, and the subsequent LFP-MEP analysis was done on successful stop trials only. Furthermore, selecting a different subset of channels (based on the maximal beta difference between successful and failed stop trials) did not change the pattern of results.
Outliers in the single-trial LFP and MEP data were diagnosed using Grubbs' test for outliers (P 5 0.05) and removed from this single-trial analysis. Each successful stop trial was then classified as either high or low in beta power, based on a median split within each subject. Successful stop trial MEP amplitudes were then averaged for high-and low-beta trials separately and tested against one another using a pairedsamples t test (P 5 0.05), which tested our hypothesis of greater MEP suppression on high-beta trials.
We used the median split method because of the high levels of noise inherent in single-trial MEP data. However, we also tested the relationship between MEP suppression and beta power on a trial-to-trial level within subjects. To this end, instead of mediansplitting single-trial MEP amplitudes based on beta power, we correlated single-trial beta-power and MEP amplitudes on successful stop trials directly within each subject using the Pearson correlation coefficient. We then tested these coefficients for significance on the group level using a truth-label-switching Monte Carlo simulation (10,000 iterations). In each iteration, we randomly shuffled the successful stop-trial LFP and MEP amplitudes within each subject and generated a group-level correlation based on the shuffled trials. The group-level (average) correlation for each iteration was then computed and compared to the actual group-level mean correlation for the actual data. The P value was then derived by comparing how many of the 10,000 group-level correlation coefficients generated based on random trials were more (or just as) positive/negative as the original coefficient. If fewer than 500 coefficients are as extreme as (or more extreme than) the original correlation coefficient, the test is significant at P 5 0.05.
Results
Behavior
Behavioral results are summarized in Table 1 . In the LFP-only phase, GoRT was greater than FsRT for all 9 participants (t (8) 5 3.8; P 5 0.005; d 5 1.18) as expected based on the race model for the stop-signal task. In the simultaneous LFP-TMS phase, GoRT was again greater than FsRT for all 9 participants (t (8) 5 8.1; P < 0.001; d 5 1.2). None of the behavioral measures differed between the LFP-only phase and the simultaneous LFP-TMS phase (cf. Table 1) , showing that the application of TMS did not significantly influence stopping behavior.
Validation: STN-LFP Beta Difference
(LFP Only) Figure 2A shows the group-level ERSP difference between successful and failed stop trials at the dipolar right STN contacts selected for the simultaneous LFP-MEP analysis (the contacts for these analyses were independently selected based on the simultaneous data set). Figure 2B shows the power spectra for these contacts. Beta-power amplitude was increased for successful versus failed stop trials right toward the end of SSRT (which is where inhibition should be maximal according to computational models of the stop-signal task 27 . The difference was significant at P 5 0.004 (two-sided) at 378 to 416 ms post-stop signal ( Fig.  2A, black outline) . No other frequency band showed significant differences between the two trial types at the corrected significance threshold. The left STN electrode also showed increased beta-band activity in a similar time range, yet this did not reach significance at the corrected threshold of P 5 0.004. 
Validation: Global CSE Suppression
Main Hypothesis: Simultaneous LFP-MEP
In line with our hypothesis, MEP amplitudes on successful stop trials were significantly smaller on trials with large STN beta amplitudes compared to trials with small beta amplitudes (t (8) 5 2.4; P 5 0.043; d 5 1.25; Fig. 3B ). Figure 4 shows the individual participants' TMS data. All but 1 participant showed numerically reduced MEPs on successful stop trials compared to go trials, and all but 2 participants showed numerically greater suppression on successful stop trials with high beta compared to low beta (1 was the aforementioned participant who showed no suppressed overall MEP). Just like for the LFP-only results, left STN electrodes showed the same numerical pattern (greater MEP suppression for high-beta trials) as right STN electrodes, yet like the LFP-only results, this did not reach significance at a two-sided P value of 0.05 (t (8) 
The result of the median split analysis for the right STN was further corroborated by the group-level correlation between single-trial beta-power and MEP amplitude on successful stop trials. The mean correlation coefficient was -0.176 (standard error of the mean [SEM]: 0.08), meaning that higher beta power on individual successful stop trials was accompanied by stronger CSE suppression (smaller MEP). Compared to the Monte Carlo distribution, this grouplevel correlation was significant at P 5 0.011.
To test whether this result was specific to action stopping or whether increased beta is merely a marker of an akinetic state that is also indexed by reduced CSE, we repeated the analysis for go trials. For this, we split go-trial MEP amplitudes by beta power in the 168-ms time window preceding the TMS pulse. Here, we did not find the same relationship (P > 0.46). In fact, go trials with large beta amplitudes had numerically larger MEPs than go trials with small beta amplitudes. Thus, the relation between increased beta and lower CSE was specific to successful stop trials. This suggests that increased beta is not merely a marker of an akinetic state, but a functional marker of a process elicited specifically during successful stopping.
Discussion
While participants performed a vocal stop-signal task, we recorded LFPs from the STN and simultaneously Left column: LFP-only phase; right column: simultaneous LFP-TMS phase. P values denote significance of a two-sided paired-samples t test for differences between the two phases.
FIG. 2. (A)
Full-spectrum ERSP data from the LFP-only phase (no TMS; the bipolar STN channels underlying this figure were selected from the simultaneous LFP-TMS data to perform the main analysis in Fig. 3) . Depicted is the difference between successful and failed stop trials, timelocked to the stop signal (STOP): red: successful > failed; blue: failed > successful. Black outline: P < 0.00417. (B) Individual channel power spectra for each selected channel. Note the uptick in beta power in each individual channel. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.] delivered TMS over the hand area of M1. We replicated studies showing increased beta-band STN power for successful versus failed stop trials 11, [14] [15] [16] and also studies showing that action stopping reduces CSE in taskirrelevant motor effectors. [5] [6] [7] [8] Most important, our main analysis showed that global motor suppression on successful stop trials is directly related to increased rightlateral beta-band STN activity. These results firmly establish increased STN beta-band activity as a signature of response inhibition in humans, and go further by showing that STN activity is related to the "global" nature of the suppression.
Our central finding linking global motor suppression on successful stop trials to STN activity is consistent with influential models of the basal ganglia. Based on some anatomical evidence for divergent projections from the STN to the output nuclei of the basal ganglia (globus pallidus and SNc 20, 28 ), these models propose that a corticosubthalamic "hyperdirect" pathway inhibits large areas of the thalamus and cerebral cortex (albeit as part of movement initiation and not rapid stopping 22, 23 ). Related to this concept, it has been proposed that the STN implements a global "NoGo" signal during decision conflict to momentarily withhold responding or "hold your horses." 29 Our findings suggest that CSE reductions from task-irrelevant effectors and STN beta-band power are indeed markers of such global suppression. This is relevant for many studies that have either shown STN activity during decision (and other) conflict, [30] [31] [32] movement selection, 33 switching, 34 or posterror slowing. 35, 36 Our study shows a correlation between STN activity and global suppression. We are mindful that a correlation between two variables (STN activity and global CSE suppression) does not exclude the possibility that a third process explains both of them and neither can it speak to the directional nature of the relationship. For example, increased arousal during successful stopping could lead to a phasic release of dopamine. The dopamine system influences GABAergic interneurons, 37 which could result in reduced MEPs from M1. Such catecholamine release/arousal could also potentially lead to beta-band increases in the STN. 38 However, we find this explanation unlikely, because it predicts increased catecholamine release/arousal on failed stop trials; yet, beta-band power on such trials was significantly smaller compared to successful stop trials, and the same was true for the amount of global CSE suppression (both of which are in line with previous studies).
We found the association between the STN-LFP and CSE only for the right STN. This is in line with our previous fMRI study, which showed that the right STN is engaged in stopping to a greater extent than the left STN, 12 as well as a meta-analytic search of the term "response inhibition" on neurosynth.org.
This study had some limitations. First, though we recorded LFP from the STN alone, similar beta-band changes may occur in other basal ganglia nuclei. 39 Whether an increase in beta-band power in other parts of the basal ganglia/thalamocortical circuit is related to stopping-induced changes in CSE will require further study. Ultimately, a strong demonstration that the STN is causally important for global motor suppression will require optogenetic or electrical stimulation, or measuring CSE during stopping in patients with STN lesions (c.f. Obeso and colleagues 19 ). Second, because these results were obtained from pathological brains, it cannot be assumed that these results apply to the healthy population. However, our PD patient sample showed increased activity in the STN during stopping that is in line with fMRI data from healthy participants. 12 Furthermore, the patients' MEP data showed the same stopping-related global reduction of motor excitability that is found in the healthy population. [5] [6] [7] [8] Third, our sample size of 9 patients is only modest. This reflects the difficulties in recruiting and performing the study in advanced PD patients who recently had DBS surgery, and the considerable technical difficulty of simultaneously delivering TMS and recording LFP from the STN, moreover for a vocal stop-signal task for which TMS stimulation was timelocked to a real-time forecast of GoRT. Still, the sample size is similar to other studies of LFP during cognitive tasks. Moreover, we validated two wellestablished effects (global CSE suppression and successful-vs. failed-stop STN beta-band increase) in our sample before testing our main hypothesis. Additionally, our tests of the main hypothesis yielded a large effect size of d 5 1.25 in the median split analysis, which was also confirmed as a single trial correlation with a group-level P value of 0.011.
From a clinical perspective, our results have implications for the use of STN-DBS in PD. First, although STN-DBS improves motor performance in PD patients, it may impair functions that rely on global motor suppression. It has been proposed that perceptual or decision conflict recruit the STN, which ostensibly raises the decision threshold for multiple response channels (alternatively, this could be seen as a suppression of activity of these channels 3, 27, 40, 41 ). The consequence is to hold back all response tendencies and buy time to accumulate more evidence about the correct action. STN-DBS has been shown to interfere with the normal ability to slow down responses in such high-conflict conditions, so that patients instead respond more quickly/impulsively (i.e., they make more errors 40, 42, 43 ). Our demonstration that global motor suppression is linked to STN activity provides more evidence for this model, which helps explain how and why STN-DBS induces impulsivity. Second, beta oscillations have been proposed as a feedback signal for closed-loop DBS. 44 Our findings suggest that algorithms for closed-loop DBS should take into account changes in beta oscillations in a behavioral context. Third, by linking the STN signature with CSE, our results suggest that the CSE measure could potentially be used a proxy of STN function (at least in global suppression mode). This may be useful in future assessments of PD patients when STN-LFP recordings are not possible.
In summary, rapid action stopping has global motor effects, and we show that these effects are related to beta-band activity within the STN. These results validate a core prediction of several basal ganglia models, which propose a broad suppressive impact of the STN on motor representations.
